Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

280 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
PARP-1 inhibition with or without ionizing radiation confers reactive oxygen species-mediated cytotoxicity preferentially to cancer cells with mutant TP53.
Liu Q, Gheorghiu L, Drumm M, Clayman R, Eidelman A, Wszolek MF, Olumi A, Feldman A, Wang M, Marcar L, Citrin DE, Wu CL, Benes CH, Efstathiou JA, Willers H. Liu Q, et al. Among authors: efstathiou ja. Oncogene. 2018 May;37(21):2793-2805. doi: 10.1038/s41388-018-0130-6. Epub 2018 Mar 7. Oncogene. 2018. PMID: 29511347 Free PMC article.
Multidisciplinary care and pursuit of active surveillance in low-risk prostate cancer.
Aizer AA, Paly JJ, Zietman AL, Nguyen PL, Beard CJ, Rao SK, Kaplan ID, Niemierko A, Hirsch MS, Wu CL, Olumi AF, Michaelson MD, D'Amico AV, Efstathiou JA. Aizer AA, et al. Among authors: efstathiou ja. J Clin Oncol. 2012 Sep 1;30(25):3071-6. doi: 10.1200/JCO.2012.42.8466. Epub 2012 Jul 30. J Clin Oncol. 2012. PMID: 22851571
Bladder preservation therapy for muscle-invading bladder cancers on Radiation Therapy Oncology Group trials 8802, 8903, 9506, and 9706: vascular endothelial growth factor B overexpression predicts for increased distant metastasis and shorter survival.
Lautenschlaeger T, George A, Klimowicz AC, Efstathiou JA, Wu CL, Sandler H, Shipley WU, Tester WJ, Hagan MP, Magliocco AM, Chakravarti A. Lautenschlaeger T, et al. Among authors: efstathiou ja. Oncologist. 2013 Jun;18(6):685-6. doi: 10.1634/theoncologist.2012-0461. Epub 2013 May 31. Oncologist. 2013. PMID: 23728940 Free PMC article.
Models of care and NCCN guideline adherence in very-low-risk prostate cancer.
Aizer AA, Paly JJ, Zietman AL, Nguyen PL, Beard CJ, Rao SK, Kaplan ID, Niemierko A, Hirsch MS, Wu CL, Olumi AF, Michaelson MD, D'Amico AV, Efstathiou JA. Aizer AA, et al. Among authors: efstathiou ja. J Natl Compr Canc Netw. 2013 Nov;11(11):1364-72. doi: 10.6004/jnccn.2013.0160. J Natl Compr Canc Netw. 2013. PMID: 24225970
Cervical brachytherapy exchange: steps toward oncology capacity building in Botswana.
Bvochara-Nsingo M, Grover S, Gierga DP, Makufa R, Efstathiou JA, Dixit N, Clayman RH, Russell AH, Lin LL, Kasese J. Bvochara-Nsingo M, et al. Among authors: efstathiou ja. Oncologist. 2014 Jul;19(7):e1-2. doi: 10.1634/theoncologist.2013-0393. Epub 2014 Jun 13. Oncologist. 2014. PMID: 24928614 Free PMC article.
Prognostic factors and outcomes in primary urethral cancer: results from the international collaboration on primary urethral carcinoma.
Gakis G, Morgan TM, Efstathiou JA, Keegan KA, Mischinger J, Todenhoefer T, Schubert T, Zaid HB, Hrbacek J, Ali-El-Dein B, Clayman RH, Galland S, Olugbade K Jr, Rink M, Fritsche HM, Burger M, Chang SS, Babjuk M, Thalmann GN, Stenzl A, Daneshmand S. Gakis G, et al. Among authors: efstathiou ja. World J Urol. 2016 Jan;34(1):97-103. doi: 10.1007/s00345-015-1583-7. Epub 2015 May 17. World J Urol. 2016. PMID: 25981402 Free PMC article.
280 results